These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21528083)

  • 21. SPARCL1 expression increases with preoperative radiation therapy and predicts better survival in rectal cancer patients.
    Kotti A; Holmqvist A; Albertsson M; Sun XF
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1196-202. PubMed ID: 24661672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.
    Nasif WA; Lotfy M; El-Sayed IH; El-Kenawy Ael-M; El-Shahat M; El-Hak NG
    Med Oncol; 2006; 23(2):237-44. PubMed ID: 16720924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma.
    Losi L; Ponti G; Gregorio CD; Marino M; Rossi G; Pedroni M; Benatti P; Roncucci L; de Leon MP
    Pathol Res Pract; 2006; 202(9):663-70. PubMed ID: 16860493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
    Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
    Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer.
    Kwak JM; Lee HJ; Kim SH; Kim HK; Mok YJ; Park YT; Choi JS; Moon HY
    World J Gastroenterol; 2010 Aug; 16(31):3897-904. PubMed ID: 20712050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mismatch repair protein MSH2, cytokeratin 18 and cytokeratin 20 expression: clinicopathological correlation and prognostic value in colorectal cancer patients.
    González JJ; Bernardo CG; Sanz L; Fresno MF; Barbón E; Noval JG; Martínez E
    Hepatogastroenterology; 2007 Dec; 54(80):2266-71. PubMed ID: 18265645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma.
    Naschberger E; Liebl A; Schellerer VS; Schütz M; Britzen-Laurent N; Kölbel P; Schaal U; Haep L; Regensburger D; Wittmann T; Klein-Hitpass L; Rau TT; Dietel B; Méniel VS; Clarke AR; Merkel S; Croner RS; Hohenberger W; Stürzl M
    J Clin Invest; 2016 Nov; 126(11):4187-4204. PubMed ID: 27721236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer.
    Huang Y; Wang J; Cao F; Jiang H; Li A; Li J; Qiu L; Shen H; Chang W; Zhou C; Pan Y; Lu Y
    Sci Rep; 2017 Dec; 7(1):17597. PubMed ID: 29242509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods.
    Zakout YM; Lanza G
    J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.
    Zheng L; Xie G; Duan G; Yan X; Li Q
    PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
    Yi W; Xiao E; Ding R; Luo P; Yang Y
    Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The high expression of p53 in sporadic colorectal carcinoma is associated with metastasis and decreased survival.
    Pancione M; Forte N; Campione S; Napolitano A; Parente D; Sabatino L; Febbraro A; Colantuoni V
    Pathologica; 2010 Apr; 102(2):51-6. PubMed ID: 23596757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissues.
    Klingler A; Regensburger D; Tenkerian C; Britzen-Laurent N; Hartmann A; Stürzl M; Naschberger E
    PLoS One; 2020; 15(5):e0233422. PubMed ID: 32437418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53, Cyclin-D1, β-catenin, APC and c-myc in Tumor Tissue from Colorectal and Gastric Cancer Patients with Suspected Lynch Syndrome by the Bethesda Criteria.
    Marcolino TF; Pimenta CAM; Artigiani Neto R; Castelo P; Silva MS; Forones NM; Oshima CTF
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):343-348. PubMed ID: 32102509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mismatch repair protein MSH2 expression and prognosis of colorectal cancer patients.
    Bernardo CG; González JJ; Sanz L; Barbón E; Noval JG; Fresno MF; Aza J
    Int J Biol Markers; 2004; 19(3):190-5. PubMed ID: 15503820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
    Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
    World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation.
    Yang Z; Zhang C; Qi W; Cui C; Cui Y; Xuan Y
    Exp Mol Pathol; 2018 Oct; 105(2):216-222. PubMed ID: 30170017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
    Gao M; Zhang X; Li D; He P; Tian W; Zeng B
    Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of MutL homologue MLH1 and MutS homologue MSH2 expression in Turkish patients with sporadic colorectal cancer.
    Erdamar S; Ucaryilmaz E; Demir G; Karahasanoglu T; Dogusoy G; Dirican A; Goksel S
    World J Gastroenterol; 2007 Sep; 13(33):4437-44. PubMed ID: 17724798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
    Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
    Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.